SCHEMBL8780658

SCHEMBL8780658

[2H]CO[C@@H](C(=O)O)[C@@H](O)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
SLC1A1 P43005 1/20 0.38
TP53 P04637 1/20 0.33
PGD P52209 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7290471 0.82 SLC1A3 (0.54) TSHRSLC1A3SLC1A2SLC1A1TP53
SCHEMBL722389 0.82 SLC1A3 (0.54) TSHRSLC1A3SLC1A2SLC1A1TP53
SCHEMBL7291825 0.82 SLC1A3 (0.54) TSHRSLC1A3SLC1A2SLC1A1TP53
SCHEMBL27742181 0.80 SLC1A3 (0.52) TSHRSLC1A3SLC1A2SLC1A1TP53
Ethylene Glycol SCHEMBL3744577 0.74 SLC1A3 (0.46) TSHRSLC1A3SLC1A2SLC1A1TP53
Propylene Glycol SCHEMBL3726880 0.71 SLC1A3 (0.43) TSHRSLC1A3SLC1A2SLC1A1TP53
1,4-Butanediol SCHEMBL3733977 0.71 SLC1A3 (0.43) TSHRSLC1A3SLC1A2SLC1A1PGD
SCHEMBL915072 0.71 TSHR (0.53) TSHRSLC1A3SLC1A2SLC1A1TP53
SCHEMBL20839610 0.69 TSHR (0.50) TSHRSLC1A3SLC1A2SLC1A1TP53
SCHEMBL1068276 0.69 TSHR (0.50) TSHRSLC1A3SLC1A2SLC1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5658880-A PREVENT SELECTIN BINDING; ANTIINFLAMMATORY, ANTICANCER AGENTS; AIDS THERAPY GLYCOMED INCORPORATED (US) 1997-08-19 US disclosed
EP-0775151-A2 SIALIC ACID/FUCOSE BASED MEDICAMENTS GLYCOMED INCORPORATED (US) 1997-05-28 EP disclosed
WO-1996005209-A9 SIALIC ACID/FUCOSE BASED MEDICAMENTS 1996-04-11 WO disclosed
WO-1996005209-A2 SIALIC ACID/FUCOSE BASED MEDICAMENTS GLYCOMED, INCORPORATED (US) 1996-02-22 WO disclosed